|Articles|October 1, 2021

In case you missed it: Sept. 27 to Oct. 1

It's been a busy week for the Contemporary OB/GYN® team.

Here's what you missed this week on Contemporary OB/GYN®:

Screening for sexual infections critical as cases rise

Not only are chlamydia and gonorrhea 2 of the most common sexually transmitted infections (STIs) in the United States, but people are being diagnosed with them at a higher rate than ever before, according to the Centers for Disease Control and Prevention (CDC).

Uptake of NIPT lower in disadvantaged neighborhoods

Noninvasive prenatal testing (NIPT) uptake is significantly lower in socioeconomically disadvantaged neighborhoods compared to all other neighborhoods in the Netherlands, according to a study in the journal Prenatal Diagnosis.

No specific dietary adjustments increase quality of life in endometriosis patients

An online explorative observational study in the journal Reproductive BioMedicine Online has found that there are no specific dietary adjustments to increase quality of life among Dutch endometriosis patients.

More pregnant women using cannabis amid pandemic

A study released in JAMA reveals a 25% increase in cannabis use in pregnant women during the pandemic in the United States.

Intervention fails to improve teen-to-teen contraceptive communication

Remote delivery of the SpeakOut intervention failed to increase communication, knowledge, and use of contraception among teens and their peers, according to a recently published study.

Newsletter

Get the latest clinical updates, case studies, and expert commentary in obstetric and gynecologic care. Sign up now to stay informed.

Related to this article

Who is a candidate for testosterone therapy in women?

November 6th, 2026

FAQ: Who is a candidate for testosterone therapy in women?

This FAQ summarizes a Special Report discussion on how two experts decide who is a candidate for testosterone therapy in women, from symptoms and context to hormone state vs age.

FAQ: What does the evidence show about testosterone in women?

November 6th, 2026

FAQ: What does the evidence show about testosterone in women?

This FAQ summarizes a Special Report discussion of what the evidence does and does not establish about testosterone therapy in women.

Q&A: Kanchi Chadha, MD, FACOG, MSCP, on FDA boxed warning removals

November 6th, 2026

Q&A: Kanchi Chadha, MD, FACOG, MSCP, on FDA boxed warning removals

Kanchi Chadha, MD, FACOG, MSCP, supports reconsidering MHT boxed warnings but says the FDA cited no study behind the change.

HRSA opens $1 million funding to update women's preventive guidelines | Image credit: stock.adobe.com

November 6th, 2026

HRSA opens $1 million funding to update women's preventive guidelines

HRSA will award up to $1 million to a single organization to update the Women's Preventive Services Guidelines through the new WISH program.

Maternal RSVpreF vaccine tied to fewer infant RSV hospitalizations | Image credit: stock.adobe.com

November 6th, 2026

Maternal RSVpreF vaccine tied to fewer infant RSV hospitalizations

Real-world data show maternal RSVpreF vaccination was 82% effective against infant RSV LRTI hospitalization through 3 months.

Q&A: Soma Mandal, MD, MSCP, on FDA boxed warning removals for MHT

November 5th, 2026

Q&A: Soma Mandal, MD, MSCP, on FDA boxed warning removals for MHT

Soma Mandal, MD, MSCP, says removing MHT boxed warnings is overdue but calls for transparency on the FDA's product-specific rationale.

Centers for Medicare, Medicaid Services includes AMA's obstetric codes in 2027 fee schedule | Image credit: Contemporary OB/GYN

November 5th, 2026

Centers for Medicare, Medicaid Services includes AMA's obstetric codes in 2027 fee schedule

CMS' proposed G-codes, which experts stated would cause confusion in combination with the AMA's proposed codes, were not included in the final fee schedule for 2027, according to ACOG.

Matthew Nudy, MD, on estrogen and the cardiovascular system

November 4th, 2026

Matthew Nudy, MD, on estrogen and the cardiovascular system

Matthew Nudy, MD, on estrogen's cardiovascular effects, risk assessment, and hormone therapy safety in younger menopausal women.

Trending on Contemporary OB/GYN

Centers for Medicare, Medicaid Services includes AMA's obstetric codes in 2027 fee schedule

Diagnosing Sleep Disturbances Beyond VMS in Menopause

Reactions to FDA's boxed warning removals for menopausal hormone therapy

Top video interviews from The Menopause Society 2026 Annual Meeting

Q&A: Peter Hsin, BS, on perioperative ketamine and early postpartum depression